Medical News

RSS

NIH names UTHealth as one of 25 regional stroke centers

The University of Texas Health Science Center at Houston has been named one of 25 regional stroke centers by the National Institutes of Health and the only one in Texas.

14 Dec 2013

Savient gets bankruptcy court approval to sell all assets to Crealta

Savient Pharmaceuticals, Inc. announced that it has received approval from the U.S. Bankruptcy Court for the District of Delaware to sell substantially all of the assets of Savient, including all KRYSTEXXA assets, to Crealta Pharmaceuticals LLC.

13 Dec 2013

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved the single tablet HIV-1 regimen Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) for use in certain virologically-suppressed (HIV RNA <50 copies/mL) adult patients on a stable antiretroviral regimen in order to replace their current antiretroviral treatment regimen. Complera was first approved in 2011 for patients new to therapy and is now one of the most widely-prescribed HIV regimens in the United States.

13 Dec 2013

Study shows effectiveness of PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced new results from a combined analysis of the Austrian Breast & Colorectal Cancer Study Group 8 (ABCSG-8) and Trans-Arimidex, Tamoxifen, Alone or in Combination (TransATAC) studies. These results, which evaluated samples from 2,137 patients, suggest that the PAM50-based Prosignaz Breast Cancer Prognostic Gene Signature Assay may help identify women with late distant recurrence after five years of endocrine treatment.

13 Dec 2013

Health Canada approves Genzyme's Lemtrada for adults with relapsing remitting multiple sclerosis

Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.

13 Dec 2013

6MWT wording change could enhance serial utility

Researchers have found that the distance patients cover during the 6-minute walk test depends on the instructions they are given, indicating that changing the current protocol may enhance the accuracy and reproducibility of the test.

13 Dec 2013

Quitting cannabis improves psychosis treatment adherence

Quitting cannabis appears to improve medication adherence in the long-term among patients admitted for first-episode psychosis, researchers have found.

13 Dec 2013

Bipolar disorder patients hold contradictory self-associations

Symptomatic bipolar disorder patients have a marked discrepancy between their automatic and “thought-out” views of themselves, research suggests.

13 Dec 2013

Cetuximab fails in second-line combination for recurrent NSCLC

Results from a phase III trial indicate that cetuximab should not be given alongside chemotherapy in patients with recurrent non-small-cell lung cancer after platinum-based therapy.

13 Dec 2013

Clinical psychologist provides tips to survive holiday season without weight gain

Special family meals, holiday buffets and free drinks can be open invitations for disaster for the more than 50 percent of Americans who are struggling with their weight and dieting.

13 Dec 2013

Budget deal, with 3-month 'doc fix' moves to Senate

As the the House approved a budget deal, Republicans included a provision to prevent a scheduled pay cut for doctors who treat Medicare patients.

13 Dec 2013

Children can reap positive health benefits from increased physical activity

Studies conducted by the Appalachian State University Human Performance Laboratory at the NC Research Campus in Kannapolis, N.C., show that when children increase their level of physical activity, they experience positive health benefits quickly.

13 Dec 2013

Many health law exchange plans have 'narrow networks'

Some new health insurance plans sold through the health law's online insurance exchanges -- in an effort to keep premiums down -- severely limit where new enrollees can get care.

13 Dec 2013

Indegene’s MCM division launches Brand-Focused Solutions for brand marketing teams

Indegene, a leading provider of R&D, commercial, and marketing solutions to top global pharmaceutical and healthcare organizations, today announced that its Multi-channel Marketing (MCM) division has launched a suite of Brand-Focused Solutions for the brand marketing teams.

13 Dec 2013

Specialists use pioneering treatment to reduce high blood pressure in kidney patient

SPECIALISTS at Sheffield Teaching Hospitals NHS Foundation Trust have used a pioneering treatment to reduce high blood pressure in a kidney patient whose blood pressure could not be controlled with conventional medication.

13 Dec 2013

Deep genome sequencing used to predict clinical outcomes in patients with breast cancer tumors

New research from University Hospitals (UH) Case Medical Center Seidman Cancer Center and Case Comprehensive Cancer Center at Case Western Reserve University examined how changes in the genetic composition of breast cancer tumors after brief exposure to either biologic therapy or chemotherapy can predict future clinical outcomes in patients.

13 Dec 2013

Artificial sweetener sucralose has biological effects

The artificial sweetener sucralose is a biologically active compound according to an extensive review published by Taylor & Francis in the recent issue of Journal of Toxicology and Environmental Health, Part B: Critical Reviews. "Sucralose, A Synthetic Organochlorine Sweetener: Overview Of Biological Issues" authored by Susan S. Schiffman, PhD, an internationally known sweetener researcher and Kristina I. Rother, MD, MHSc, of the National Institutes of Health (NIH), summarizes the biological properties of sucralose based on hundreds of archival, peer-reviewed scientific journal publications.

13 Dec 2013

Medical News

NIH names UTHealth as one of 25 regional stroke centers

Savient gets bankruptcy court approval to sell all assets to Crealta

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

Study shows effectiveness of PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay

Health Canada approves Genzyme's Lemtrada for adults with relapsing remitting multiple sclerosis

6MWT wording change could enhance serial utility

Quitting cannabis improves psychosis treatment adherence

Bipolar disorder patients hold contradictory self-associations

Cetuximab fails in second-line combination for recurrent NSCLC

Clinical psychologist provides tips to survive holiday season without weight gain

Budget deal, with 3-month 'doc fix' moves to Senate

Children can reap positive health benefits from increased physical activity

Many health law exchange plans have 'narrow networks'

Indegene’s MCM division launches Brand-Focused Solutions for brand marketing teams

Specialists use pioneering treatment to reduce high blood pressure in kidney patient

Deep genome sequencing used to predict clinical outcomes in patients with breast cancer tumors

Artificial sweetener sucralose has biological effects

First Edition: December 13, 2013

CEO Cancer Gold Standard accreditation awarded to Boehringer Ingelheim Pharmaceuticals

Geriatrician draws specific conclusions about Santa’s health habits

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News